CRT 2024

CARDIOTUBE INTERVIEW - First-in-Man Evaluation of Intracoronary Cryotherapy for Vulnerable Plaque Stabilization

Interviewer(s)

• 

  Spencer B. King, III, MD, MACC, MSCAI

  Professor of Medicine Emeritus
  Emory University
  Atlanta, Georgia, United States

  No relationships to disclose

Interviewee(s)

• 

  Carlos Collet, MD

  Co-director cath lab
  OLV Aalst, Belgium

  Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Advisor (Ongoing), Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant/Advisory Board (Ongoing), Consulting fees or other remuneration (Ongoing), Contracted Research (Ongoing); cryotherapeutics: Advisor (Ongoing), Contracted Research (Ongoing); GE Healthcare: Advisor (Ongoing), Clinical Trial Investigator (Ongoing), Grants/Research Support Recipient (Ongoing), Honoraria (Ongoing); Heartflow, Inc: Advisor (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Fees for Non-CME Services Received Directly from Commercial Interest or their Agents (e.g., speakers' bureaus) (Ongoing)